A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)
Clinical trial NCT05526521 · COMPLETED
Trial details
- NCT number
- NCT05526521
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-25
- Primary completion
- 2024-11-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.